Indapta Therapeutics
1 follower
‌
Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.
Industries
Headquarters
Employees
Links
Org chart
Mark W. Frohlich
Collapse
Robert Sikorski
Acting Chief Medical Officer
Austin Bigley
VP, Research
Ronald Martell
Co-Founder, Executive Chairman
Moya Daniels
Regulatory Affairs Consultant
Similar companies
Synthekine
3 followers
Forge Biologics
2 followers
Kyverna Therapeutics
5 followers
Day One Biopharmaceuticals
1 follower
Obsidian Therapeutics
1 follower
Bionaut Labs
1 follower
Ventyx Biosciences
1 follower
Slingshot Biosciences
1 follower
Generate Biomedicines
3 followers
OrganaBio
1 follower
Cellares
2 followers
Discover companies